SCI Abstract

search
Nanoparticle-based pazopanib shows promise in OA
A nanoparticle-based formulation of the anticancer drug pazopanib, which inhibits VEGFR1 and VEGFR2, shows promise as a di...
Low-frequency and rare genetic variants associated with rheumatoid arthritis risk
Low-frequency and rare genetic variants associated with rheumatoid arthritis risk
Rheumatoid arthritis (RA) has an estimated heritability of nearly 50%, which is particularly high in seropositive RA. HLA ...
Author Correction: Proposals for the rheumatological use of JAK inhibitors
Authors and AffiliationsUniversity della Campania, Department of Precision Medicine, Naples, ItalyFrancesco CicciaUniversi...
Time for a new approach to drug development for rare systemic autoinflammatory diseases
Despite the transformative potential of treatments for systemic autoinflammatory diseases, these conditions remain underfu...
Author Correction: Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells
Author notesThese authors contributed equally: Christian Jorgensen, Danièle Noël.Authors and AffiliationsIRMB, University ...
Biological and clinical roles of IL-18 in inflammatory diseases
Biological and clinical roles of IL-18 in inflammatory diseases
Several new discoveries have revived interest in the pathogenic potential and possible clinical roles of IL-18. IL-18 is a...
Nanohybrid therapy hits multiple arthritis targets
A novel combination of ceria nanoparticles and mesenchymal stem cell nanovesicles modified both inflammation and autoimmun...
Shifting the SLE management paradigm: challenges and implications
Shifting the SLE management paradigm: challenges and implications
Newly published European guidelines for the management of systemic lupus erythematosus (SLE) and lupus nephritis, specific...
Primary care rheumatology: towards sustainable development in health
Globally, rheumatic musculoskeletal diseases constitute the most common causes of disability, related morbidity and econom...
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Anti-melanoma differentiation-associated protein 5 (MDA5) antibody-positive dermatomyositis (MDA5-DM) is a subtype of derm...
Profiling joint tissues at single-cell resolution: advances and insights
Profiling joint tissues at single-cell resolution: advances and insights
Advances in the profiling of human joint tissues at single-cell resolution have provided unique insights into the organiza...
Targeted NOD2 sequencing uncovers JIA misdiagnosis
New findings support the use of targeted next-generation sequencing of NOD2 to reassess the diagnosis of juvenile idiopath...
Single-cell atlas unveils the diversity of RA synovial tissue
Researchers have conducted a comprehensive single-cell analysis of synovial tissue in rheumatoid arthritis, providing insi...
Multi-omics reveals distinct MPA subtypes
Using multi-omics analyses, researchers have identified two distinct immunological phenotypes of microscopic polyangiitis,...
l-arginine inhibits arthritis and bone loss by reprogramming osteoclast metabolism
New research shows that the amino acid l-arginine ameliorates arthritis and inhibits inflammatory bone loss by altering en...
Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis
Predominant ligament-centric soft-tissue involvement differentiates axial psoriatic arthritis from ankylosing spondylitis
Since the original description of spondyloarthritis 50 years ago, results have demonstrated similarities and differences b...
25 years of biologic DMARDs in rheumatology
25 years of biologic DMARDs in rheumatology
2023 marks 25 years since the approval of the first biologic drug in rheumatology. In this Viewpoint, five rheumatology re...
Immune mechanisms of depression in rheumatoid arthritis
Immune mechanisms of depression in rheumatoid arthritis
Depression is a common and disabling comorbidity in rheumatoid arthritis that not only decreases the likelihood of remissi...
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions
Systemic sclerosis (SSc), or scleroderma, is a rare, complex, systemic autoimmune disease of unknown aetiology, characteri...
Treatment of systemic juvenile idiopathic arthritis
Treatment of systemic juvenile idiopathic arthritis
Systemic juvenile idiopathic arthritis (sJIA) is an inflammatory disease with hallmarks of severe systemic inflammation, w...
Methotrexate improves pain in hand OA
Methotrexate reduces pain and stiffness in hand osteoarthritis with synovitis, according to the results of a new randomize...
Are TNF inhibitors still the agent of choice for RA?
Since entering the clinic 25 years ago, biologic TNF inhibitors have transformed the outlook for people with rheumatoid ar...
Epidemiology of the idiopathic inflammatory myopathies
Epidemiology of the idiopathic inflammatory myopathies
The idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of systemic autoimmune diseases that affect the sk...
Rheumatoid arthritis prevention in arthralgia: fantasy or reality?
Rheumatoid arthritis prevention in arthralgia: fantasy or reality?
The concept of a ‘window of opportunity’ in treating a disease assumes the existence of a time frame during wh...
Pre-exposure prophylaxis reduces risk of COVID-19
In an observational study, SARS-CoV-2 antibody therapy used as pre-exposure prophylaxis reduced the incidence of COVID-19 ...
FGF signalling implicated in relapsing RA
New research shows that the FGF10–FGFR1 axis is highly activated in lining fibroblast-like synoviocytes during relap...